Stem Cell Articles


Hansson E, Chien K. Reprogramming a Broken Heart. Cell Stem Cell. 2012; 11(1): 3-4.

Burridge P, Keller G, Gold J, Wu J. Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct Reprogramming. Cell Stem Cell. 2011; 10(1): 16-28.

Schneider M. EPO and Super-EPO: Erythropoietins Direct Neoangiogenesis by Cardiac Progenitor Cells. Cell Stem Cell. 2011; 9(2): 95-96.

Hoch M, Fischer P, Stapel B, Missol-Kolka E, et al. Erythropoietin Preserves the Endothelial Differentiation Capacity of Cardiac Progenitor Cells and Reduces Heart Failure during Anticancer Therapies. Cell Stem Cell. 2011; 9(2): 131-143.

Arnold C. Texas stem cell rules may impede clinical research. Lancet. 2012; 379(9828): 1776.

Ranganath S, Levy O, Inamdar M, Karp J. Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease. Cell Stem Cell. 2012; 10(3): 244-258.

Morrisey E. Rewind to Recover: Dedifferentiation after Cardiac Injury. Cell Stem Cell. 2011; 9(5): 387-388.

Perin C, Silva G, Zheng Y, Gahremanpour A, et al. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehyrogenase-bright stem cells in patients with ischemic heart failure. American Heart Journal. 2012; 163(3): 415-421.

Kubin T, Pöling J, Kostin S, Gajawada P, et al. Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling. Cell Stem Cell. 2011; 9(5): 420-432.

Chong J, Chandrakanthan V, Xaymardan M, Asil, N, et al. Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial Origin. Cell Stem Cell. 2011; 9(6): 527-540.

Traverse J, Henry T, Moyé L. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging. American Heart Journal. 2011; 162(4): 671-677.

Friedewald V, Hare J, Miller L, Walpole H, et al. The Editor’s Roundtable: Advances in Stem Cell Therapy for Treatment of Cardiovascular Disease. The American Journal of Cardiology. 2012; 110(6): 807-816.